메뉴 건너뛰기




Volumn 34, Issue 4, 2000, Pages 1169-1194

New drug innovation and pharmaceutical industry structure: Trends in the output of pharmaceutical firms

Author keywords

Innovation; NCE; Output concentration; Success rate; Therapeutic class

Indexed keywords

ARTICLE; DRUG APPROVAL; DRUG DEVELOPMENT; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG MARKETING; DRUG RESEARCH; PRIORITY JOURNAL; UNITED STATES;

EID: 0033696580     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286150003400425     Document Type: Article
Times cited : (46)

References (34)
  • 8
    • 0000742314 scopus 로고
    • Competitive advantages from in-house scientific research: The US pharmaceutical industry in the 1980s
    • (1992) Research Policy , vol.21 , pp. 391-407
    • Gambardella, A.1
  • 13
    • 0007069894 scopus 로고    scopus 로고
    • The role of mega-mergers in the future of the pharma industry
    • Feb 10
    • (1997) Pharma Marketletter , vol.24 , Issue.6 , pp. 26-27
  • 19
    • 28844470694 scopus 로고
    • New studies on market definition, concentration, theory of supply, entry, and promotion
    • Chien RI, ed. Issues in Pharmaceutical Economics. Lexington, MA: DC Heath;
    • (1979)
    • Grabowski, H.G.1    Vernon, J.2
  • 22
    • 11044230569 scopus 로고
    • Structural effects of regulation on innovation in the ethical drug industry
    • Mason RT, Qualls PT, eds. Essays on Industrial Organization in Honor of Joe Bain. Cambridge, MA: Ballinger
    • (1976)
    • Grabowski, H.G.1    Vernon, J.2
  • 24
    • 0040690816 scopus 로고
    • Product innovation and the dynamic elements of competition in the ethical pharmaceutical industry
    • Helms RB, ed. Drug Development and Marketing. Washington, DC: American Enterprise Institute
    • (1975)
    • Cocks, D.L.1
  • 29
  • 32
    • 0004146993 scopus 로고    scopus 로고
    • In Quest of Tomorrow's Medicines
    • New York: Springer-Verlag
    • (1998)
    • Drews, J.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.